MANF protects dopamine neurons and locomotion defect from Neurotoxin/Human alpha-synuclein-induced progressive Parkinson’s disease models in C.elegans.
Objective: To study whether Mesencephalic astrocyte-derived neurotrophic factor (MANF) has beneficial effects in parkinson disease and its intracellular mechanisms. Background: The distinguishing feature of Parkinson’s…Prediction of cognitive progression in Parkinson’s disease using three cognitive screening measures
Objective: To assess the utility of commonly used cognitive screening tools in predicting the transition to mild cognitive impairment (MCI) and/or dementia (PDD) in Parkinson’s…Spiral Analysis is a Promising Biomarker in LRRK2 G2019S carriers
Objective: To assess whether harboring a LRRK2 G2019S mutation is associated with abnormalities in spiral drawing, including in mutation carriers with Parkinson Disease (PD) as…Expression of OX40 and OX40 serum level in patients with Parkinson’s disease
Objective: Study the expression of OX40 gene and its serum levels could be measured to predict and confirm diagnosis of Parkinson's disease and help develop new…Suicidality in Parkinson’s Disease: A Case Control Study
Objective: To investigate suicidality in Parkinson's disease (PD) by a case control study Background: Depression, a risk factor for suicidality, is rather common in PD patients. Nevertheless,…Sports or no sports – is that the question in PD?
Objective: A multitude of risk factors or protective factors in developing Parkinson’s Disease (PD) are under discussion, as caffeine consumption or smoking .. Background: Frequent physical activity…Association of vitamin D deficiency in Parkinson disease
Objective: To identify the association between vitamin D deficiency and PD in an Arab cohort. Background: A growing body of evidence suggests that vitamin D…The Pull Test in healthy subjects and Parkinson´s disease: quantitative pull-force measure, postugraphic and electromyographic analysis
Objective: To study and compare in healthy subjects and patients with Parkinson´s disease (PD) the destabilizing force needed to reach the limit of stability (LoS), the displacements of…Slow Release Fixed Dose Combination of Low Doses Pramipexole and Rasagiline (P2B001) for the Treatment of Early Parkinson’s Disease (PD).
Objective: Evaluation of the efficacy and safety of a slow release low dose combination of pramipexole (PPX) and rasagiline (RAS) (P2B001) in a prospective double-blind…Comparison of hand functions between people with Parkinson’s disease and healthy subjects
Objective: To compare the hand functions between Parkinson’s Disease (PD) and healthy subjects using objective and subjective measures; and to establish the correlations among outcome…
- « Previous Page
- 1
- …
- 278
- 279
- 280
- 281
- 282
- …
- 388
- Next Page »